This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Michelson A (2004) Platelet function testing in cardiovascular disease. Circulation 110: e489–e493
Topol EJ (2000) The future of antiplatelet therapy: optimizing management in patients with acute coronary syndrome. Clin Cardiol 23 (Suppl 6): SVI-23–SVI-28
Sztriha LK et al. (2005) Aspirin resistance in stroke: 2004. J Neurol Sci 229–230: 163–169
Sanderson S et al. (2005) Narrative review: aspirin resistance and its clinical implications. Ann Intern Med 142: 370–380
Serrano P et al. (2002) Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 16: 1945–1953
Acknowledgements
The synopsis was written by Emma Campbell, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Mark Alberts has received a speaker fee from Dade Behring, Inc.
Rights and permissions
About this article
Cite this article
Alberts, M. Can point-of-care platelet-function tests be used to screen for aspirin responsiveness after TIA and stroke?. Nat Rev Neurol 1, 76–77 (2005). https://doi.org/10.1038/ncpneuro0054
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0054